The effect of telemonitoring on quality of life in people with insulin‐treated type 2 diabetes: A secondary analysis of a randomised controlled trial
Authors' conclusion
Telemonitoring had no effect on general QoL but led to a statistically significant improvement in diabetes-specific QoL.
Study context
- Population
- People with insulin-treated T2D
- Participants
- 331 people
- Comparison
- Telemonitoring vs usual care for 3 months
- Telemonitoringn = 166
- Usual caren = 165reference
- Primary endpoint
- Changes in SF-12 and DAWN2 Impact of Diabetes Profile (DIDP)
- Follow-up
- 3 months
Methodological detailsANCOVA with baseline scores as covariates for normally distributed data; Mann-Whitney U test for non-normally distributed outcomes
- ANCOVA with baseline scores as covariates for normally distributed data; Mann-Whitney U test for non-normally distributed outcomes
Primary result
As reported in the abstract
General and diabetes-specific quality of life (QoL)
- Telemonitoring vs Usual care: P = 0.102
- Telemonitoring vs Usual care: P = 0.566
- Telemonitoring vs Usual care: P = 0.015
Original publication
The effect of telemonitoring on quality of life in people with insulin‐treated type 2 diabetes: A secondary analysis of a randomised controlled trial. Diabet Med. Published 18 August 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →